Healthcare provider profile · identity verified

Nermina Covic, M.D

Internal Medicine · NORTH CANTON, OH · NPI 1639606486

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	631	186
Amlodipine Besylate	Amlodipine Besylate	392	118
Lisinopril	Lisinopril	354	103
Levothyroxine Sodium	Levothyroxine Sodium	313	96
Losartan Potassium	Losartan Potassium	309	104
Omeprazole	Omeprazole	295	97
Metoprolol Succinate	Metoprolol Succinate	283	90
Hydrochlorothiazide	Hydrochlorothiazide	185	62
Furosemide	Furosemide	173	55
Albuterol Sulfate Hfa	Albuterol Sulfate	171	67
Fluticasone Propionate	Fluticasone Propionate	155	67
Metformin Hcl	Metformin Hcl	152	45
Sertraline Hcl	Sertraline Hcl	151	40
Simvastatin	Simvastatin	147	41
Pantoprazole Sodium	Pantoprazole Sodium	145	42
Metformin Hcl Er	Metformin Hcl	127	37
Pravastatin Sodium	Pravastatin Sodium	125	33
Alprazolam	Alprazolam	124	29
Trazodone Hcl	Trazodone Hcl	122	35
Tamsulosin Hcl	Tamsulosin Hcl	121	44
Ezetimibe	Ezetimibe	115	35
Rosuvastatin Calcium	Rosuvastatin Calcium	112	43
Lorazepam	Lorazepam	110	21
Potassium Chloride	Potassium Chloride	110	32
Jardiance	Empagliflozin	106	29
Duloxetine Hcl	Duloxetine Hcl	105	21
Metoprolol Tartrate	Metoprolol Tartrate	105	37
Gabapentin	Gabapentin	102	37
Meloxicam	Meloxicam	98	26
Clonazepam	Clonazepam	96	13
Allopurinol	Allopurinol	92	31
Clopidogrel	Clopidogrel Bisulfate	89	26
Alendronate Sodium	Alendronate Sodium	83	23
Eliquis	Apixaban	80	26
Ozempic	Semaglutide	73	20
Atenolol	Atenolol	71	17
Montelukast Sodium	Montelukast Sodium	71	17
Prednisone	Prednisone	71	42
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	68	17
Azithromycin	Azithromycin	67	50
Tramadol Hcl	Tramadol Hcl	67	32
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	67	15
Bupropion Xl	Bupropion Hcl	65	17
Buspirone Hcl	Buspirone Hcl	62	18
Glimepiride	Glimepiride	62	16
Glipizide	Glipizide	61	22
Tizanidine Hcl	Tizanidine Hcl	61	29
Carvedilol	Carvedilol	58	20
Xarelto	Rivaroxaban	58	14
Lovastatin	Lovastatin	55	21
Celecoxib	Celecoxib	54	14
Citalopram Hbr	Citalopram Hydrobromide	53	18
Zolpidem Tartrate	Zolpidem Tartrate	52	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	13
Pregabalin	Pregabalin	50	suppressed
Nifedipine Er	Nifedipine	49	14
Escitalopram Oxalate	Escitalopram Oxalate	48	25
Fenofibrate	Fenofibrate Nanocrystallized	46	14
Glipizide Er	Glipizide	44	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	43	34
Famotidine	Famotidine	42	18
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	38	suppressed
Finasteride	Finasteride	37	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	15
Methylprednisolone	Methylprednisolone	37	23
Hydralazine Hcl	Hydralazine Hcl	33	12
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Spironolactone	Spironolactone	33	suppressed
Nystatin	Nystatin	31	18
Doxycycline Hyclate	Doxycycline Hyclate	30	20
Mounjaro	Tirzepatide	28	suppressed
Amoxicillin	Amoxicillin	27	24
Hydrocortisone	Hydrocortisone	27	22
Valsartan	Valsartan	27	suppressed
Lansoprazole	Lansoprazole	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Captopril	Captopril	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Lacosamide	Lacosamide	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	17
Ondansetron Hcl	Ondansetron Hcl	21	13
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	17
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Sildenafil Citrate	Sildenafil Citrate	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	11
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Spiriva Handihaler	Tiotropium Bromide	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Cephalexin	Cephalexin	16	13
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Colchicine	Colchicine	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	13	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Temazepam	Temazepam	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Diazepam	Diazepam	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Baclofen	Baclofen	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Insulin Lispro	Insulin Lispro	11	suppressed
Lactulose	Lactulose	11	suppressed
Megestrol Acetate	Megestrol Acetate	11	suppressed
Minocycline Hcl	Minocycline Hcl	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error